Readout of telephone call held between HRH the Crown Prince and Prime Minister and the CEO and President of Vertex Pharmaceuticals

A telephone call was held today between His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister and Dr Reshma Kewalramani, the CEO and President of Vertex Pharmaceuticals.

His Royal Highness highlighted the Kingdom’s medical milestone in successfully completing the treatment of the world’s first sickle cell disease patient outside the United States of America with Casgevy (exagamglogene autotemcel), a CRISPR-based gene-editing therapy using bone marrow transplantation technology.

His Royal Highness reaffirmed the importance of strengthening the Kingdom’s partnership with Vertex Pharmaceuticals to promote future opportunities that further support the Kingdom’s health sector.

HRH Prince Salman bin Hamad noted the Kingdom’s commitment to enhancing cooperation with leading international specialised medical institutions, ensuring the Kingdom remains at the forefront of scientific advancements. His Royal Highness emphasised the importance of integrating cutting-edge treatments into healthcare and rehabilitation services for Bahrainis, underscoring this as a top priority.